|
Company | Date | Shares/units (M) | Price | Gross ($M) |
AC Immune SA (Lausanne, Switzerland; ACIU) | 9/26/16 | 6S | $11 | $66.00 |
Adalta Ltd. (Melbourne, Australia; ASX:1AD) | 8/26/16 | N/A | N/A | $7.40 |
Aeglea Biotherapeutics Inc. (Austin; AGLE) | 4/8/16 | 5.48S | $10 | $54.80 |
Asit Biotech SA (Brussels, Belgium; Euronext Exchange: ASIT) | 5/11/16 | ND | E7 | $26.50 |
Audentes Therapeutics Inc. (San Francisco; BOLD) | 7/21/16 | 5S | $15 | $75.00 |
Avexis Inc. (Bannockburn, Ill.; AVXS) | 2/11/16 | 4.75S | $20 | $95.00 |
Azurrx Biopharma Inc. (Brooklyn, N.Y.; AZRX) | 10/13/16 | 0.96S | $5.50 | $5.30 |
Beigene Co. Ltd. (Beijing; BGNE) | 2/3/16 | 7.59ADS | $24 | $182.16 |
Cellect Biotechnology Ltd. (Kfar Saba, Israel; APOP) | 8/1/16 | 1.29ADS and W for 0.969ADS | $6.50 | $8.40 |
China Resources Pharmaceutical Group (CR Pharma; Hong Kong; HK:3320) | 11/1/16 | 1,540S | HK$9.10 | $1,800.00 |
Clearside Biomedical Inc. (Alpharetta, Ga.; CLSD) | 6/2/16 | 7.2S | $7 | $50.40 |
Corvus Pharmaceuticals Inc. (Burlingame, Calif.; CRVS) | 3/24/16 | 4.7S | $15 | $70.50 |
Crispr Therapeutics AG (Cambridge, Mass.; CRSP) | 10/20/16 | 4S | $14 | $56.00 |
Editas Medicine Inc. (Cambridge, Mass.; EDIT) | 2/3/16 | 6.785S | $16 | $108.56 |
Gemphire Therapeutics Inc. (Northville, Mich.; GEMP) | 8/5/16 | 3S | $10 | $30.00 |
Gensight Biologics SA (Paris; EPA:SIGHT) | 7/14/16 | 18.6S | $8.89 | $44.40 |
Hutchison China Meditech Ltd. (Hong Kong; HCM) | 3/18/16 | 8.16ADS | $13.50 | $110.20 |
Intellia Therapeutics Inc. (Cambridge, Mass.; NTLA) | 5/6/16 | 6.9S | $18 | $124.20 |
Kadmon Holdings LLC (New York; NYSE:KDMN) | 7/28/16 | 6.25S | $12 | $75.00 |
Merus BV (Utrecht, the Netherlands; MRUS) | 5/19/16 | 6.14S | $10 | $61.40 |
Moleculin Biotech Inc. (Houston; MBRX) | 5/5/16 | 2S | $6 | $12.00 |
Motif Bio plc (London; MTFB and MTFBW) | 11/21/16 | 2.44ADS and W for 1.2ADS | $6.98 | $17.03 |
Myovant Sciences Ltd. (Hamilton, Bermuda; MYOV) | 10/28/16 | 14.5S | $15 | $217.50 |
Novan Inc. (Durham, N.C.; NOVN) | 9/22/16 | 4.72S | $11 | $51.90 |
Noxopharm Ltd. (Sydney; ASX:NOX) | 8/9/16 | 30S | $0.20 | $4.40 |
Oncobiologics Inc. (Cranbury, N.J.; ONS) | 5/13/16 | 5.833U | $6 | $35.00 |
Phaserx Inc. (Seattle; PZRX) | 5/25/16 | 3.7S | $5 | $18.50 |
Protagonist Therapeutics Inc. (Milpitas, Calif.; PTGX) | 8/12/16 | 7.5S | $12 | $90.00 |
Proteostasis Therapeutics Inc. (Cambridge, Mass.; PTI) | 2/12/16 | 6.25S | $8 | $50.00 |
Ra Pharmaceuticals Inc. (Cambridge, Mass.; RARX) | 10/27/16 | 7.04S | $13 | $91.52 |
Reata Pharmaceuticals Inc. (Irving, Texas; RETA) | 5/27/16 | 6.3S | $11 | $69.30 |
Samsung Biologics Co. Ltd. (subsidiary of Samsung Group; KOSPI; KS:207940) | 11/11/16 | N/A | N/A | $2,000.00 |
Selecta Biosciences Inc. (Watertown, Mass.; SELB) | 6/23/16 | 5S | $14 | $70.00 |
Spring Bank Pharmaceuticals Inc. (Hopkinton, Mass.; SBPH) | 5/9/16 | 0.92S | $12 | $11.00 |
Syndax Pharmaceuticals Inc. (Waltham, Mass.; SNDX) | 3/4/16 | 4.4S | $12 | $52.80 |
Syros Pharmaceuticals Inc. (Cambridge, Mass.; SYRS) | 6/30/16 | 4.6S | $12.50 | $57.50 |
Tigenix NV (Leuven, Belgium; TIG) | 12/16/16 | 2.3ADS | $15.50 | $35.65 |
Vectus Biosystems Ltd. (Sydney; ASX:VBS) | 2/23/16 | N/A | N/A | $3.60 |